CVS Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg Antihistamine, 24HR, 30 count bottle, NDC 69842-698-39, UPC 0 50428 62564 4
Published January 12, 2022 · Recall initiated: July 27, 2021
Summary
FDA records drug Class II recall D-0356-2022, published January 12, 2022 and initiated July 27, 2021. Recalling firm: Perrigo Company PLC; Status: Terminated; Reported quantity: 2,784 bottles; Lot: Lot # 1DV1855, exp 4/1/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Perrigo Company PLC
- Distributor
- Nationwide in the USA
- Lot
- Lot # 1DV1855, exp 4/1/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASevere Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle,March 2, 2022
- FDAAcetaminophen Child Bubble Gum Flavored Oral Suspension (160 mg/5 ml), 4 FL OZ (118 mL) per bottle,March 2, 2022
- FDANo Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant, 1 FL Oz (30 mL) per bottle, Distributed byMarch 2, 2022
- FDASevere Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle,March 2, 2022
- FDAKIRKLAND ALLER-FEX, Fexofenadine Hydrochloride Tablets, 180 mg/Antihistamine, 24HR, 180 count bottle, Made inJanuary 12, 2022
- FDAGoodSense Aller.Ease, Fexofenadine hydrochloride 24 HR, 180 mg tablets, 30 count bottle, Made in the CzechJanuary 12, 2022
Questions about this recall
Was CVS Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg Antihistamine, 24HR, 30 count bottle, NDC 69842-698-39, UPC 0 50428 62564 4 recalled?
Yes. FDA published recall D-0356-2022 on January 12, 2022. Reported hazard: Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter